Abstract
Non-inferiority designs in clinical trials for antithrombotic therapy in TAVR patients: did we go too far away by cutting corners?
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have